The Innate Killer Summit is your only technical, industry-focussed, end-to-end innate immune cell therapy meeting to explore frontiers in immunobiology, genetic modification, clinical translation, scalable manufacturing, cryopreservation, and CMC.
Join over 200 experts from Fate Therapeutics, Cytovia Therapeutics, NKarta Therapeutics, Sanofi, Takeda, GSK, and more, to advance the clinical and phase development of NK, Macrophage, γδT and NKT cell therapies for liquid and solid tumors.
Realize the therapeutic potential of the next wave of cell therapies and maximize their benefits for scalable application with greater transduction efficiency, lower CRS and cheaper production compared to T-cell approaches.